Public figure profile updated for June 2026
[Synopsis here]
Researchers at the University of Edinburgh have identified distinct androgen profiles in women with endometriosis, suggesting a non-invasive blood test could diagnose the condition and cut the current nine-year average wait in the UK. The study analysed 11-oxygenated androgens, including 11-ketotestosterone, in blood samples from 159 diagnosed patients and 57 controls, achieving over 95% accuracy in identifying cases.
Vivani Medical and Novo Nordisk are exploring a long-acting semaglutide implant to maintain weight loss, potentially replacing frequent injections. The device aims to release medicine steadily for months, pending clinical and regulatory validation.
The Pentagon has rolled out annual testosterone screenings for service members aged 30 and older, with younger troops able to volunteer. Officials describe the measure as part of maintaining a “strong, resilient and capable” fighting force, while experts warn on possible health risks and ethical concerns about medical oversight.
Defense Secretary Pete Hegseth has announced a testosterone screening program for service members, extending annual checks to those 30 and older while offering voluntary testing for those under 30. Treatment remains voluntary, framed as restoring natural health rather than artificial enhancement. The move follows broader debates around testosterone policy in the administration.
The military is screening for low testosterone and offering therapy to qualified troops. Experts warn against overprescribing and emphasize that treatment targets those with clinically diagnosed deficiencies.
The military is implementing mandatory testosterone screening for troops aged 30 and older, aiming to optimize performance and longevity. Experts warn the policy lacks solid evidence and could pose health risks, particularly for women. Reports from multiple outlets highlight concerns about timing, medical guidelines, and potential overreach.
The US military is testing service members' testosterone levels and expanding access to testosterone replacement therapies (TRT) for those who qualify, as part of a broader public-health and defense strategy. Experts caution about risks, including infertility, and emphasize careful medical screening.